Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal
Trial ID or NCT#
Opioid medications are commonly used for pain relief. When given over time, physical dependence can occur. This results in unpleasant side effects--such as agitation and nausea--if opioid medications are suddenly stopped. We are interested in knowing if a medication named Ondansetron can help ease or prevent symptoms associated with opioid withdrawal. We are also interested in knowing if a similar (but more potent FDA-approved drug, palonosetron) can more effectively treat withdrawal symptoms with or without combination with an antihistamine called hydroxyzine (vistaril).
Examination of Palonosetron and Hydroxyzine Pre-treatment as a Possible Method to Reduce the Objective Signs of Experimentally-induced Acute Opioid Withdrawal in Humans: a Double-blind, Randomized, Placebo-controlled Crossover Study
- - Healthy males - Ages 18-35 - No allergies to morphine or palonosetron - No history of addiction or substance abuse
- - Female - Younger than 18 or older than 35 - History of substance abuse - Raynaud's disease or coronary artery disease - Allergies to morphine or palonosetron
Contact us to find out if this trial is right for you.